109 related articles for article (PubMed ID: 34151833)
1. AS1 expression in prostate cancer and its effects on proliferation and invasion of prostate cancer cells.
Li Y; Zhuang X; Zhuang L; Liu H
Cancer Biomark; 2021; 32(3):271-279. PubMed ID: 34151833
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway.
Li H; Jia Y; Cheng J; Liu G; Song F
Cell Death Dis; 2018 Feb; 9(2):198. PubMed ID: 29416014
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
4. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
Chang H; Li B; Zhang X; Meng X
Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
[TBL] [Abstract][Full Text] [Related]
5. NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC.
Zhou X; Bao W; Zhang D; Yang Y; Du X; Qiu G
Cancer Biol Ther; 2021 Mar; 22(3):196-203. PubMed ID: 33629937
[TBL] [Abstract][Full Text] [Related]
6. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
[No Abstract] [Full Text] [Related]
7. Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1.
Zha LF; Zhang LD; Pan HM; Ma HD
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1351-1357. PubMed ID: 33629305
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
9. NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway.
Wang B; Wang K; Jin T; Xu Q; He Y; Cui B; Wang Y
Biomed Pharmacother; 2020 Sep; 129():110395. PubMed ID: 32887025
[TBL] [Abstract][Full Text] [Related]
10. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of lncRNA NCK1-AS1 distinguished patients with prostate cancer from those with benign prostatic hyperplasia.
Guan Z; Song Y; Ma J; Li F; Zhao X; Liang G; An H; Pu J
Oncol Lett; 2019 Dec; 18(6):6379-6384. PubMed ID: 31807161
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143.
Qiao Z; Dai H; Zhang Y; Li Q; Zhao M; Yue T
Cancer Manag Res; 2020; 12():1661-1668. PubMed ID: 32184669
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NCK1-AS1-mediated regulatory functions in human diseases.
Wang Y; Pan J; Sun Z
Clin Transl Oncol; 2023 Feb; 25(2):323-332. PubMed ID: 36131072
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NCK1-AS1 in plasma distinguishes oral ulcer from early-stage oral squamous cell carcinoma.
Le F; Ou Y; Luo P; Zhong X
J Biol Res (Thessalon); 2020 Dec; 27():16. PubMed ID: 33194849
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NCK1-AS1 promotes the proliferation, migration and invasion of non-small cell lung cancer cells by acting as a ceRNA of miR-137.
Li J; Wu X; Cao W; Zhao J
Am J Transl Res; 2020; 12(10):6908-6920. PubMed ID: 33194081
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
18. Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer.
Li Z; Wang F; Zhang S
FEBS Open Bio; 2019 May; 9(5):851-858. PubMed ID: 30980513
[TBL] [Abstract][Full Text] [Related]
19. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
Tan SF; Ni JX; Xiong H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
[TBL] [Abstract][Full Text] [Related]
20. Silencing of long non-coding RNA NCK1-AS1 inhibits cell proliferation and migration via inhibition of microRNA-134 in cervical cancer.
Huang L; Gan X; He L; Wang L; Yu J
Exp Ther Med; 2019 Sep; 18(3):2314-2322. PubMed ID: 31410182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
